Evaluating the Safety and Efficacy of the Bronchodilator Navafenterol for Treatment of COPD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The European Respiratory Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
Eur. Respir. J. 2022 Apr 01;59(4)2100972, D Singh, J Beier, C Astbury, MG Belvisi, CA Da Silva, A Jauhiainen, E Jimenez, A Lei, S Necander, JA Smith, U Wählby Hamrén, W Xin, I PsallidasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.